| Particulars |
|
|
|
| Company Name
| Bafna Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
23.66 |
B.V. (₹) |
35.80 |
| Sales(₹ Cr.) |
145.86 |
NP (₹ Cr.) |
6.30 |
| NP Var% |
-14.00 |
Div% |
0.00 |
| CPS(₹) |
4.70 |
EPS (₹) |
2.70 |
| Traded Value(₹ Lakhs) |
16.22 |
52 Week High |
101.00 |
| 52 Week Low |
68.00 |
Price BSE |
101.00 |
| Price NSE |
99.00 |
Market Capital (₹ Cr.) |
239.05 |
| P/C Ratio |
21.40 |
P/E Ratio |
37.90 |
| Price Vs.BV |
2.82 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
34.62 |
| NP(₹ Cr.) |
3.39 |
NP Var % |
995.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
143.45 |
| OPM |
5.07 |
NP |
0.75 |
| NP Var% |
1527.96 |
EPS |
2.66 |
| PE |
37.99 |
|
|